| Year |
Citation |
Score |
| 2023 |
Chen M, Mor DE. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms. International Journal of Molecular Sciences. 24. PMID 37108366 DOI: 10.3390/ijms24087205 |
0.5 |
|
| 2022 |
Chen M, Vincent J, Ezeanii A, Wakade S, Yerigenahally S, Mor DE. Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models. Life Science Alliance. 5. PMID 35790300 DOI: 10.26508/lsa.202201366 |
0.443 |
|
| 2022 |
McIntyre LM, Huertas F, Morse AM, Kaletsky R, Murphy CT, Kalia V, Miller GW, Moskalenko O, Conesa A, Mor DE. GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson's disease. Scientific Reports. 12: 3268. PMID 35228596 DOI: 10.1038/s41598-022-07238-9 |
0.557 |
|
| 2021 |
Sohrabi S, Mor DE, Kaletsky R, Keyes W, Murphy CT. High-throughput behavioral screen in C. elegans reveals Parkinson's disease drug candidates. Communications Biology. 4: 203. PMID 33589689 DOI: 10.1038/s42003-021-01731-z |
0.537 |
|
| 2020 |
Mor DE, Murphy CT. Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's disease. Translational Medicine of Aging. 4: 117-120. PMID 33178902 DOI: 10.1016/J.Tma.2020.07.007 |
0.548 |
|
| 2020 |
Mor DE, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V, Miller GW, Murphy CT. Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria. Proceedings of the National Academy of Sciences of the United States of America. PMID 33024014 DOI: 10.1073/pnas.2009838117 |
0.552 |
|
| 2019 |
Mor DE, Daniels MJ, Ischiropoulos H. The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30633814 DOI: 10.1002/Mds.27607 |
0.624 |
|
| 2018 |
Yao V, Kaletsky R, Keyes W, Mor DE, Wong AK, Sohrabi S, Murphy CT, Troyanskaya OG. An integrative tissue-network approach to identify and test human disease genes. Nature Biotechnology. PMID 30346941 DOI: 10.1038/Nbt.4246 |
0.563 |
|
| 2018 |
Mor DE, Ischiropoulos H. The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease. Journal of Experimental Neuroscience. 12: 1179069518761360. PMID 29559809 DOI: 10.1177/1179069518761360 |
0.637 |
|
| 2017 |
Mor DE, Tsika E, Mazzulli JR, Gould NS, Kim H, Daniels MJ, Doshi S, Gupta P, Grossman JL, Tan VX, Kalb RG, Caldwell KA, Caldwell GA, Wolfe JH, Ischiropoulos H. Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration. Nature Neuroscience. PMID 28920936 DOI: 10.1038/Nn.4641 |
0.658 |
|
| 2016 |
Mor DE, Ugras SE, Daniels MJ, Ischiropoulos H. Dynamic structural flexibility of α-synuclein. Neurobiology of Disease. 88: 66-74. PMID 26747212 DOI: 10.1016/J.Nbd.2015.12.018 |
0.593 |
|
| 2014 |
Gould N, Mor DE, Lightfoot R, Malkus K, Giasson B, Ischiropoulos H. Evidence of native α-synuclein conformers in the human brain Journal of Biological Chemistry. 289: 7929-7934. PMID 24474688 DOI: 10.1074/Jbc.C113.538249 |
0.453 |
|
| Show low-probability matches. |